Diabetic Eye Screening (DES TAT) 25/26

{
  "awards": [
    {
      "id": "2",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Health services",
              "id": "85100000",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "services",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-PPON-PYHT-5943-VXGV",
          "name": "Gloucestershire Hospitals NHS Foundation Trust"
        }
      ]
    }
  ],
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "contracts": [
    {
      "aboveThreshold": true,
      "awardID": "2",
      "dateSigned": "2025-09-30T00:00:00+01:00",
      "documents": [
        {
          "datePublished": "2025-12-10T11:25:12Z",
          "description": "Contract details notice on Find a Tender",
          "documentType": "contractNotice",
          "format": "text/html",
          "id": "081400-2025",
          "noticeType": "UK7",
          "url": "https://www.find-tender.service.gov.uk/Notice/081400-2025"
        }
      ],
      "id": "2",
      "period": {
        "endDate": "2026-10-31T23:59:59Z",
        "startDate": "2025-10-01T00:00:00+01:00"
      },
      "status": "active",
      "title": "Diabetic Eye Screening (DES TAT) 25/26",
      "value": {
        "amount": 236547.2,
        "amountGross": 236547.2,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-12-10T11:25:12Z",
  "id": "081400-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05dacf",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "region": "UKI45",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "contactPoint": {
        "email": "sharron.giblin@nhs.net",
        "name": "Sharron Giblin"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.england.nhs.uk/"
      },
      "id": "GB-PPON-PDPT-3135-BWWY",
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "name": "NHS England",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cheltenham",
        "postalCode": "GL53 7AN",
        "region": "UKK13",
        "streetAddress": "Trust HQ  Alexandra House  Cheltenham  Gloucestershire"
      },
      "contactPoint": {
        "email": "jassy.few@nhs.net"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-PPON-PYHT-5943-VXGV",
      "identifier": {
        "id": "PYHT-5943-VXGV",
        "scheme": "GB-PPON"
      },
      "name": "Gloucestershire Hospitals NHS Foundation Trust",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "The Diabetic Eye Screening Test and Training (DES TAT) system is crucial for the NHS Diabetic Eye Screening Programme (DESP), ensuring staff are trained to detect diabetic retinopathy accurately. This vital quality assurance minimizes diagnostic variability, helping to prevent blindness in diabetic patients.\nThe Discovery project (BC-21699) will evaluate DES TAT to confirm its alignment with modern digital standards, assessing user needs, functionality, and infrastructure. The project will explore enhancements, cost-efficiencies, and potential integration with PERFORMS TAT and PERFECT TAT into a unified modular system.\nKey goals include validating user requirements, reviewing the current infrastructure for compliance and improvement, enhancing cost-efficiency, and defining a Minimum Viable Product (MVP). The aim is to modernize DES TAT while retaining essential features and exploring decommissioning outdated components.\nTo supp",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C382056",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "PA23 Sch.5 Additional or repeat goods, services or works - extension or partial replacement",
    "procurementMethodRationaleClassifications": [
      {
        "id": "additionalRepeatExtensionPartialReplacement"
      }
    ],
    "status": "complete",
    "title": "Diabetic Eye Screening (DES TAT) 25/26"
  }
}